The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 01, 2019
Filed:
Oct. 06, 2017
Applicant:
Drexel University, Philadelphia, PA (US);
Inventors:
Sandhya Kortagere, Newtown, PA (US);
Carol M. Artlett, Chesterbrook, PA (US);
Assignee:
Drexel University, Philadelphia, PA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); C07D 417/14 (2006.01); C07D 309/32 (2006.01); C07D 215/54 (2006.01); C07D 317/58 (2006.01); C07D 317/66 (2006.01); C07D 401/04 (2006.01); C07D 249/08 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 491/052 (2006.01); C07D 493/04 (2006.01); C07D 513/04 (2006.01); C07D 211/90 (2006.01); C07C 317/44 (2006.01); A61K 45/06 (2006.01); A61K 31/4162 (2006.01); A61K 31/47 (2006.01); A61K 31/167 (2006.01); A61K 31/36 (2006.01); A61K 31/427 (2006.01); A61K 31/4439 (2006.01); C07C 237/52 (2006.01); C07D 263/56 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 31/167 (2013.01); A61K 31/36 (2013.01); A61K 31/4162 (2013.01); A61K 31/427 (2013.01); A61K 31/4439 (2013.01); A61K 31/47 (2013.01); A61K 31/519 (2013.01); A61K 45/06 (2013.01); C07C 237/52 (2013.01); C07C 317/44 (2013.01); C07D 211/90 (2013.01); C07D 215/54 (2013.01); C07D 249/08 (2013.01); C07D 263/56 (2013.01); C07D 309/32 (2013.01); C07D 317/58 (2013.01); C07D 317/66 (2013.01); C07D 401/04 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/052 (2013.01); C07D 493/04 (2013.01); C07D 513/04 (2013.01); A61K 38/00 (2013.01); C07C 2601/08 (2017.05); C07C 2601/14 (2017.05);
Abstract
The present invention provides compounds useful for treating or preventing an IL-1R-mediated disease or disorder. In certain embodiments, the disease or disorder comprises scleroderma.